Ceftolozane-tazobactam and ceftazidime-avibactam efficacy against K. pneumoniae: first NDM-5 and OXA-232 report from Türkiye

Introduction: Ceftolozane-tazobactam (CLZ-TAZ) and ceftazidime-avibactam (CAZ-AVB) are recently developed β-lactam/β-lactamase inhibitor combinations active against resistant Gram-negative bacteria. This study compared the in vitro activities of ceftazidime, meropenem, piperacillin-tazobactam (PIP-...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Belgin Altun, Gülşen Hazırolan, Deniz Gür
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	The Journal of Infection in Developing Countries 2026-01-01
Cyfres:	Journal of Infection in Developing Countries
Pynciau:	K. pneumoniae carbapenem-resistance ceftolozan-tazobactam ceftazidime-avibactam OXA-232 NDM-5
Mynediad Ar-lein:	https://jidc.org/index.php/journal/article/view/21385
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!